This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid | MicrobiomeTrials
← Back to trials NCT03295383
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2019-07-11Est. Completion: 2027-03
Enrollment target: 92 participantsLocations CHU Amiens, Amiens, France CHU Angers, Angers, France CH Argenteuil, Argenteuil, France CHU Bordeaux, Bordeaux, France Brest University Hospital, Brest, France CHU Caen, Caen, France CHU Clermont Ferrand, Clermont-Ferrand, France CHU Dijon, Dijon, France CH Le Mans, Le Mans, France CHU Lille, Lille, France CHU de Limoges, Limoges, France HCL, Lyon, France APHM La Timone, Marseille, France CHU Montpellier, Montpellier, France CHU Nantes, Nantes, France CHU Nice, Nice, France APHP Avicennes, Paris, France APHP Bichat, Paris, France APHP Cochin, Paris, France APHP Henri Mondor, Paris, France APHP Pitié Salpétrière, Paris, France APHP Saint-Louis, Paris, France CH Quimper, Quimper, France Other microbiome trials you might be interested in Pemphigoid
In patients with gingival cicatricial pemphigoid (CP), clinical experience has shown that periodontal treatment is benef…
Nice, France Completed Jun 30, 2022
CHU de Reims, Reims, France
CHU Rennes, Rennes, France
CHU saint-Etienne, Saint-Etienne, France
CHU Tours, Tours, France